The latest closing stock price for Beam Therapeutics as of November 20, 2024 is 24.49.
An investor who bought $1,000 worth of Beam Therapeutics stock at the IPO in 2020 would have $306 today, roughly 0 times their original investment - a 5.49% compound annual growth rate over 5 years.
The all-time high Beam Therapeutics stock closing price was 133.60 on July 01, 2021.
The Beam Therapeutics 52-week high stock price is 49.50, which is 102.1% above the current share price.
The Beam Therapeutics 52-week low stock price is 20.84, which is 14.9% below the current share price.
The average Beam Therapeutics stock price for the last 52 weeks is 26.86.
An investor who bought $1,000 worth of Beam Therapeutics stock at the IPO in 2020 would have $306 today, roughly 0 times their original investment - a 5.49% compound annual growth rate over 5 years.
The all-time high Beam Therapeutics stock closing price was 133.60 on July 01, 2021.
The Beam Therapeutics 52-week high stock price is 49.50, which is 102.1% above the current share price.
The Beam Therapeutics 52-week low stock price is 20.84, which is 14.9% below the current share price.
The average Beam Therapeutics stock price for the last 52 weeks is 26.86.